Kiek dividendų moka Bausch Health Companies 2025?
Pagal paskutinę informaciją nuo Sausis 2025, Bausch Health Companies per paskutinius 12 mėnesių mokėjo bendrą dividendą, kuris sudarė 3,98 USD už akciją. Esant dabartiniam Bausch Health Companies kursui 7,49 USD, tai atitinka 53,16 % dividendų grąžą.
Dividendai mokami kartus per metus.
17,08 % Dividendo grąža | = | 1,28 USD Dividendas | 7,49 USD akcijų kaina |
|
Ar Bausch Health Companies dividendai yra saugūs?
Bausch Health Companies kasmet didina dividendus jau 2 metus.
Per pastaruosius 10 metus Bausch Health Companies kasmet 0 % sumažinta.
Per 5 metų laikotarpį krito išmokos padidėjo 0 %.
Analitikai prognozuoja, kad einamaisiais verslo metais Dividendų mažinimas bus 0%.
Bausch Health Companies Aktienanalyse
Ką daro Bausch Health Companies?
Bausch Health Companies Inc is a Canadian pharmaceutical company that was founded in 2013. However, the company's history dates back to 1853 when John Jacob Bausch and Henry Lomb founded their own company in the USA. This company specialized in optical products, particularly eyeglass frames and lenses. Over the years, the company expanded its product range and also became involved in the production of contact lenses in the 1960s.
In the 1970s, the company began to focus on the medical devices sector and expanded in this area through various acquisitions. In the 1990s, the company also established itself in the pharmaceutical sector by building various channels for the distribution of medications.
In 2013, the company was renamed and restructured due to financial problems, and in the future, it operated under the name Bausch Health Companies Inc.
The company's business model is based on the development, manufacture, and marketing of products in the medical and ophthalmology fields. The company works closely with various institutions such as doctors, pharmacies, and hospitals to ensure that its products are used optimally. The company operates in various areas, including:
- Ophthalmology: Bausch Health Companies offers various products in the field of ophthalmology, including contact lenses, eye drops, and other medications that can be used to treat eye diseases such as cataracts or glaucoma.
- Dermatology: The company also develops and markets products in the field of dermatology, including medications for the treatment of acne, rosacea, and psoriasis.
- Gastroenterology: Bausch Health Companies also produces medications for the treatment of gastrointestinal diseases, such as medications for ulcers or inflammatory bowel diseases.
- Neurology: The company manufactures medications for the treatment of neurological disorders, such as epilepsy or migraines.
- Urology: Bausch Health Companies also offers products in the field of urology, including medications for the treatment of urinary tract infections or bladder problems.
One of the most well-known products of Bausch Health Companies is the brand Bausch + Lomb, which operates in the field of ophthalmology and offers various contact lenses and eye drops. Another well-known product is Jublia, a medication for nail fungus.
Overall, Bausch Health Companies is a leading company in the field of medicine and ophthalmology with a long history. With its diverse range of medications and products, it offers effective and reliable solutions for the treatment of various conditions to patients worldwide. Bausch Health Companies yra viena populiariausių įmonių Eulerpool.com svetainėje.Akcijų taupymo planai siūlo patrauklią galimybę investuotojams ilgalaikėje perspektyvoje kurti turtą. Vienas pagrindinių privalumų yra vadinamasis vidutinės išlaidos efektas: reguliariai investuojant fiksuotą sumą į akcijas arba akcijų fondus, automatiškai perkama daugiau dalinių vertybių popierių, kai kainos yra žemos, ir mažiau – kai jos aukštos. Tai gali lemti palankesnę vidutinę dalies kainą per laiką. Be to, akcijų taupymo planai suteikia galimybę ir smulkiesiems investuotojams patekti į brangias akcijas, nes jie gali dalyvauti jau su mažomis sumomis. Reguliarus investavimas taip pat skatina disciplinuotą investavimo strategiją ir padeda išvengti emociškai pagrįstų sprendimų, pavyzdžiui, impulsyvaus pirkimo ar pardavimo. Be to, investuotojai gauna naudos iš potencialaus akcijų vertės augimo bei iš dividendų, kurie gali būti reinvestuoti, kas sustiprina sudėtinio palūkanų efektą ir taip skatina investuoto kapitalo augimą.
Bausch Health Companies akcija yra taupoma šiuose teikėjuose: Trade Republic